SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17975181
Source:
http://linkedlifedata.com/resource/pubmed/id/17975181
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008976
,
umls-concept:C0034656
,
umls-concept:C0073393
,
umls-concept:C1269683
pubmed:issue
9
pubmed:dateCreated
2007-11-2
pubmed:databankReference
http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00095134
pubmed:abstractText
Major depressive disorder has high prevalence, morbidity, and mortality. Inadequate results with antidepressants have prompts addition of a nonstandard treatment (augmentation therapy).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17975181-17975178
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17975181-18669679
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372351
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Antipsychotic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Risperidone
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1539-3704
pubmed:author
pubmed-author:CanusoCarla MCM
,
pubmed-author:Gharabawi-GaribaldiGeorges MGM
,
pubmed-author:Kosik-GonzalezColetteC
,
pubmed-author:KujawaMary JMJ
,
pubmed-author:MahmoudRamy ARA
,
pubmed-author:PandinaGahan JGJ
,
pubmed-author:TurkozIbrahimI
pubmed:issnType
Electronic
pubmed:day
6
pubmed:volume
147
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
593-602
pubmed:dateRevised
2008-8-18
pubmed:meshHeading
pubmed-meshheading:17975181-Adolescent
,
pubmed-meshheading:17975181-Adult
,
pubmed-meshheading:17975181-Aged
,
pubmed-meshheading:17975181-Antidepressive Agents
,
pubmed-meshheading:17975181-Antipsychotic Agents
,
pubmed-meshheading:17975181-Depressive Disorder, Major
,
pubmed-meshheading:17975181-Double-Blind Method
,
pubmed-meshheading:17975181-Drug Therapy, Combination
,
pubmed-meshheading:17975181-Female
,
pubmed-meshheading:17975181-Follow-Up Studies
,
pubmed-meshheading:17975181-Humans
,
pubmed-meshheading:17975181-Male
,
pubmed-meshheading:17975181-Middle Aged
,
pubmed-meshheading:17975181-Prospective Studies
,
pubmed-meshheading:17975181-Quality of Life
,
pubmed-meshheading:17975181-Remission Induction
,
pubmed-meshheading:17975181-Risperidone
pubmed:year
2007
pubmed:articleTitle
Risperidone for treatment-refractory major depressive disorder: a randomized trial.
pubmed:affiliation
Ortho-McNeil Janssen Scientific Affairs, Titusville, New Jersey, USA. rmahmou@ethus.jnj.com
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study